74%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
74%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
74%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
74%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
English (International)
Pfizer
Open
Sector Healthcare
25.84 -0.04
Overview
Share price change
24h
Min
25.75
Max
26.07
Income | -4.1B 410M |
|---|---|
Sales | 63M 18B |
P/E Sector Avg | 18.362 73.394 |
EPS | 0.63 |
Dividend yield | 6.64 |
Profit margin | 2.308 |
EBITDA | -6.1B 729M |
Recommendations | Buy |
|---|---|
12 Months Forecast | +19.42 upside |
Dividend yield Sector Avg | 6.64% 3.09% |
|---|---|
Next Earnings | 30 Apr 2025 |
Next Dividend date | 7 Mar 2025 |
Next Ex Dividend date | 8 May 2025 |
Market Cap | -4.5B 147B |
|---|---|
Previous open | 25.88 |
Previous close | 25.84 |
News Sentiment
By Acuity
32%
68%
105 / 393 Healthcare
Technical Score
By Trading Central
Confidence
Neutral Evidence
Pfizer Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Pfizer Forecast
Price Target
By TipRanks
19.42% upside
12 Months Forecast
Average 30.93 USD 19.42%
High 36 USD
Low 28 USD
Based on 17 Wall Street analysts offering 12 month price targets forPfizer - Dist in the last 3 months.
Sentiment
By Acuity
105 / 393 Healthcare
News Sentiment
Bullish Evidence
Volatility
Below average
News Volume (RCV)
Above average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About Pfizer
Pfizer Inc. (Pfizer) is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products. Its global portfolio includes medicines and vaccines. The Company works across markets to develop wellness, prevention, treatments and cures. It collaborates with healthcare providers, governments and local communities to support and provide access to healthcare. Its medicines and vaccines provide value for healthcare providers and patients, through treatment of diseases, improvements in health, wellness. It sells its prescription pharmaceutical products to wholesalers, retailers, hospitals, clinics, government agencies and pharmacies. In the United States, it sells its vaccines products to the federal government, centers for disease control and prevention (CDC), wholesalers, individual provider offices, retail pharmacies and integrated delivery networks.
